FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078609815> ?p ?o ?g. }

• W2078609815 endingPage "371" @default.
• W2078609815 startingPage "369" @default.
• W2078609815 abstract "Background Treatment options for multiple sclerosis (MS) are limited. The immunomodulatory drugs interferon beta and glatiramer acetate are only partly effective in reducing the relapse rate, slowing disease progression, and diminishing the number and volume of lesions on MRI. Mitoxantrone is an immunosuppressant approved for the treatment of active forms of relapsing-remitting or secondary progressive MS, but is dose-limited owing to its potential cardiotoxicity. Thus, identifying new effective therapeutic options with few side-effects is highly desirable. Recent developments Evidence has emerged that statins, which are inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase, have immunomodulatory effects. Recent reports showed that statins prevent and reverse chronic and relapsing experimental autoimmune encephalomyelitis, an animal model of MS. Furthermore, in vitro experiments with human immune cells have shown an immunomodulatory profile of statins comparable to that of interferon beta. An open label clinical trial of simvastatin for MS revealed a significant decrease in the number and volume of new MRI lesions and a favourable safety profile. Where next? The obvious advantage of statins over existing MS therapies is their oral route of dosing. Statins might be beneficial for MS patients as monotherapy or as an add-on to established disease modifying drugs. As the evidence of the benefit of statins in MS is currently insufficient, large controlled clinical trials are needed. The first of these trials is about to start." @default.
• W2078609815 created "2016-06-24" @default.
• W2078609815 creator A5028232512 @default.
• W2078609815 creator A5030982118 @default.
• W2078609815 creator A5035339589 @default.
• W2078609815 creator A5074759103 @default.
• W2078609815 date "2004-06-01" @default.
• W2078609815 modified "2023-09-27" @default.
• W2078609815 title "Are statins a treatment option for multiple sclerosis?" @default.
• W2078609815 cites W1479880028 @default.
• W2078609815 cites W1525331105 @default.
• W2078609815 cites W1547957565 @default.
• W2078609815 cites W1907316344 @default.
• W2078609815 cites W1977595948 @default.
• W2078609815 cites W1980857453 @default.
• W2078609815 cites W1983692527 @default.
• W2078609815 cites W1992540727 @default.
• W2078609815 cites W1999895981 @default.
• W2078609815 cites W2008690571 @default.
• W2078609815 cites W2017885661 @default.
• W2078609815 cites W2027428178 @default.
• W2078609815 cites W2030144209 @default.
• W2078609815 cites W2033968552 @default.
• W2078609815 cites W2043180355 @default.
• W2078609815 cites W2045160039 @default.
• W2078609815 cites W2050561275 @default.
• W2078609815 cites W2057349194 @default.
• W2078609815 cites W2059510434 @default.
• W2078609815 cites W2068867459 @default.
• W2078609815 cites W2074996264 @default.
• W2078609815 cites W2083485745 @default.
• W2078609815 cites W2088800018 @default.
• W2078609815 cites W2088865411 @default.
• W2078609815 cites W2092189787 @default.
• W2078609815 cites W2098946775 @default.
• W2078609815 cites W2103856558 @default.
• W2078609815 cites W2106173673 @default.
• W2078609815 cites W2112098540 @default.
• W2078609815 cites W2116887543 @default.
• W2078609815 cites W2124546623 @default.
• W2078609815 cites W2136622296 @default.
• W2078609815 cites W2161821089 @default.
• W2078609815 cites W2338977280 @default.
• W2078609815 doi "https://doi.org/10.1016/s1474-4422(04)00770-7" @default.
• W2078609815 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15157852" @default.
• W2078609815 hasPublicationYear "2004" @default.
• W2078609815 type Work @default.
• W2078609815 sameAs 2078609815 @default.
• W2078609815 citedByCount "71" @default.
• W2078609815 countsByYear W20786098152012 @default.
• W2078609815 countsByYear W20786098152013 @default.
• W2078609815 countsByYear W20786098152014 @default.
• W2078609815 countsByYear W20786098152015 @default.
• W2078609815 countsByYear W20786098152016 @default.
• W2078609815 countsByYear W20786098152017 @default.
• W2078609815 countsByYear W20786098152021 @default.
• W2078609815 countsByYear W20786098152022 @default.
• W2078609815 countsByYear W20786098152023 @default.
• W2078609815 crossrefType "journal-article" @default.
• W2078609815 hasAuthorship W2078609815A5028232512 @default.
• W2078609815 hasAuthorship W2078609815A5030982118 @default.
• W2078609815 hasAuthorship W2078609815A5035339589 @default.
• W2078609815 hasAuthorship W2078609815A5074759103 @default.
• W2078609815 hasConcept C126322002 @default.
• W2078609815 hasConcept C143998085 @default.
• W2078609815 hasConcept C203014093 @default.
• W2078609815 hasConcept C2776036978 @default.
• W2078609815 hasConcept C2776694085 @default.
• W2078609815 hasConcept C2778486448 @default.
• W2078609815 hasConcept C2778577042 @default.
• W2078609815 hasConcept C2779384338 @default.
• W2078609815 hasConcept C2780640218 @default.
• W2078609815 hasConcept C2780923524 @default.
• W2078609815 hasConcept C2781004633 @default.
• W2078609815 hasConcept C535046627 @default.
• W2078609815 hasConcept C71924100 @default.
• W2078609815 hasConcept C98274493 @default.
• W2078609815 hasConceptScore W2078609815C126322002 @default.
• W2078609815 hasConceptScore W2078609815C143998085 @default.
• W2078609815 hasConceptScore W2078609815C203014093 @default.
• W2078609815 hasConceptScore W2078609815C2776036978 @default.
• W2078609815 hasConceptScore W2078609815C2776694085 @default.
• W2078609815 hasConceptScore W2078609815C2778486448 @default.
• W2078609815 hasConceptScore W2078609815C2778577042 @default.
• W2078609815 hasConceptScore W2078609815C2779384338 @default.
• W2078609815 hasConceptScore W2078609815C2780640218 @default.
• W2078609815 hasConceptScore W2078609815C2780923524 @default.
• W2078609815 hasConceptScore W2078609815C2781004633 @default.
• W2078609815 hasConceptScore W2078609815C535046627 @default.
• W2078609815 hasConceptScore W2078609815C71924100 @default.
• W2078609815 hasConceptScore W2078609815C98274493 @default.
• W2078609815 hasIssue "6" @default.
• W2078609815 hasLocation W20786098151 @default.
• W2078609815 hasLocation W20786098152 @default.
• W2078609815 hasOpenAccess W2078609815 @default.
• W2078609815 hasPrimaryLocation W20786098151 @default.
• W2078609815 hasRelatedWork W2001220614 @default.
• W2078609815 hasRelatedWork W2002450319 @default.

• next